Abstract P2-08-01: Factors predicting relapse in early breast cancer patients with a pathological complete response after neoadjuvant therapy – Results of a pooled analysis based on the GBG meta-database

Complete Response ◽

Pooled Analysis ◽

Factors predicting relapse in early breast cancer patients with a pathological complete response after neoadjuvant therapy: Pooled analysis based on the GBG database

Annals of Oncology ◽

10.1093/annonc/mdz097 ◽

2019 ◽

Vol 30 ◽

pp. iii34 ◽

Cited By ~ 1

Author(s):

J. Huober ◽

A. Schneeweiss ◽

J.-U. Blohmer ◽

C. Denkert ◽

C. Hanusch ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Early Breast Cancer ◽

Complete Response ◽

Pooled Analysis ◽

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

Oncotarget ◽

10.18632/oncotarget.2449 ◽

2014 ◽

Vol 5 (20) ◽

pp. 9619-9625 ◽

Cited By ~ 22

Author(s):

Patrizia Vici ◽

Marcella Mottolese ◽

Laura Pizzuti ◽

Maddalena Barba ◽

Francesca Sperati ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Complete Response ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: Focus on Ki-67 and molecular subtypes

Annals of Oncology ◽

10.1093/annonc/mdz097.012 ◽

2019 ◽

Vol 30 ◽

pp. iii37

Author(s):

B.L. Rapoport ◽

J. Barnard-Tidy ◽

R.I. Van Eeden ◽

T. Smit ◽

S. Nayler ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Breast Cancer ◽

Molecular Subtypes ◽

Complete Response ◽

Breast Cancer Patients ◽

Ki 67

Magseed®-guided long-term marking of target lymph nodes in neoadjuvant therapy of early breast cancer patients - first experiences and prospectives

10.1055/s-0040-1710735 ◽

2020 ◽

Author(s):

M Thill ◽

T Schnitzbauer

Keyword(s):

Breast Cancer ◽

Lymph Nodes ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Early Breast Cancer ◽

Magseed®-guided long-term marking of target lymph nodes in neoadjuvant therapy of early breast cancer patients – first experiences and prospectives

10.1055/s-0040-1717878 ◽

2020 ◽

Author(s):

M Thill ◽

F Khandan ◽

T Schnitzbauer

Keyword(s):

Breast Cancer ◽

Lymph Nodes ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Early Breast Cancer ◽

Tumor histological subtyping determined by hormone receptors and HER2 status defines different pathological complete response and outcome to dose-dense neoadjuvant chemotherapy in breast cancer patients

Clinical & Translational Oncology ◽

10.1007/s12094-013-1116-z ◽

2013 ◽

Vol 16 (6) ◽

pp. 548-554 ◽

Cited By ~ 6

Author(s):

A. Sánchez-Muñoz ◽

Y. Plata-Fernández ◽

M. Fernández ◽

A. Jaén-Morago ◽

M. Fernández-Navarro ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Hormone Receptors ◽

Complete Response ◽

Her2 Status ◽

Breast Cancer Patients ◽

Dose Dense

Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR)

Annals of Surgical Oncology ◽

10.1245/s10434-020-09548-6 ◽

2021 ◽

Author(s):

Minhao Lv ◽

Juntao Li ◽

Huihui Guo ◽

Chao Wang ◽

Peiqi Tian ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Cancer Patients ◽

Lymph Node Dissection ◽

Complete Response ◽

Breast Cancer Patients ◽

Node Dissection ◽

Supraclavicular Lymph Node

Prognostic factors associated with pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: The importance of Ki-67 and molecular subtype

Annals of Oncology ◽

10.1093/annonc/mdy270.230 ◽

2018 ◽

Vol 29 ◽

pp. viii75

Author(s):

B.L. Rapoport ◽

J.A. Barnard-Tidy ◽

T. Smit ◽

S.J. Nayler ◽

C.A. Benn

Keyword(s):

Breast Cancer ◽

Prognostic Factors ◽

Cancer Patients ◽

Molecular Subtype ◽

Complete Response ◽

Breast Cancer Patients ◽

Ki 67 ◽

Factors Associated

Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experience

Breast Cancer Research and Treatment ◽

10.1007/s10549-019-05444-0 ◽

2019 ◽

Vol 179 (1) ◽

pp. 101-111 ◽

Cited By ~ 2

Author(s):

Nicolò Matteo Luca Battisti ◽

Victoria True ◽

Narda Chaabouni ◽

Neha Chopra ◽

Karla Lee ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Systemic Therapy ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Complete Response ◽

Breast Cancer Patients ◽

Neoadjuvant Systemic Therapy

254P Different patterns of distant recurrence depending on the expression of hormone receptor in breast cancer patients with pathological complete response to neoadjuvant chemotherapy

Annals of Oncology ◽

10.1016/j.annonc.2020.08.063 ◽

2020 ◽

Vol 31 ◽

pp. S341

Author(s):

J. Ponce ◽

A. Rodriguez-Lescure ◽

S. Delgado ◽

H. Ballester ◽

M. Pastor-Valero ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Hormone Receptor ◽

Response To Neoadjuvant Chemotherapy

Complete Response ◽

Distant Recurrence ◽

Breast Cancer Patients ◽